Literature DB >> 28177603

Pro-Inflammatory and Pro-Fibrogenic Effects of Ionic and Particulate Arsenide and Indium-Containing Semiconductor Materials in the Murine Lung.

Wen Jiang1, Xiang Wang1, Olivia J Osborne1, Yingjie Du1, Chong Hyun Chang1, Yu-Pei Liao2, Bingbing Sun1, Jinhong Jiang1, Zhaoxia Ji1, Ruibin Li1,3, Xiangsheng Liu2, Jianqin Lu2, Sijie Lin1,4, Huan Meng2, Tian Xia1,2, André E Nel1,2.   

Abstract

We have recently shown that the toxicological potential of GaAs and InAs particulates in cells is size- and dissolution-dependent, tending to be more pronounced for nano- vs micron-sized particles. Whether the size-dependent dissolution and shedding of ionic III-V materials also apply to pulmonary exposure is unclear. While it has been demonstrated that micron-sized III-V particles, such as GaAs and InAs, are capable of inducing hazardous pulmonary effects in an occupational setting as well as in animal studies, the effect of submicron particles (e.g., the removal of asperities during processing of semiconductor wafers) is unclear. We used cytokine profiling to compare the pro-inflammatory effects of micron- and nanoscale GaAs and InAs particulates in cells as well as the murine lung 40 h and 21 days after oropharyngeal aspiration. Use of cytokine array technology in macrophage and epithelial cell cultures demonstrated a proportionally higher increase in the levels of matrix metalloproteinase inducer (EMMPRIN), macrophage migration inhibitory factor (MIF), and interleukin 1β (IL-1β) by nanosized (n) GaAs and n-InAs as well as As(III). n-GaAs and n-InAs also triggered higher neutrophil counts in the bronchoalveolar lavage fluid (BALF) of mice than micronscale particles 40 h post-aspiration, along with increased production of EMMPRIN and MIF. In contrast, in animals sacrificed 21 days after exposure, only n-InAs induced fibrotic lung changes as determined by increased lung collagen as well as increased levels of TGF-β1 and PDGF-AA in the BALF. A similar trend was seen for EMMPRIN and matrix metallopeptidase (MMP-9) levels in the BALF. Nano- and micron-GaAs had negligible subacute effects. Importantly, the difference between the 40 h and 21 days data appears to be biopersistence of n-InAs, as demonstrated by ICP-OES analysis of lung tissue. Interestingly, an ionic form of In, InCl3, also showed pro-fibrogenic effects due to the formation of insoluble In(OH)3 nanostructures. All considered, these data indicate that while nanoscale particles exhibit increased pro-inflammatory effects in the lung, most effects are transient, except for n-InAs and insoluble InCl3 species that are biopersistent and trigger pro-fibrotic effects. These results are of potential importance for the understanding the occupational health effects of III-V particulates.

Entities:  

Keywords:  III−V materials; lung fibrosis; lung inflammation; occupational disease; pro-inflammatory cytokine; size

Mesh:

Substances:

Year:  2017        PMID: 28177603      PMCID: PMC5543990          DOI: 10.1021/acsnano.6b07895

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  62 in total

Review 1.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

2.  Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells.

Authors:  A Barchowsky; E J Dudek; M D Treadwell; K E Wetterhahn
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

3.  Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.

Authors:  Wulf Sienel; Bernhard Polzer; Karimah Elshawi; Michael Lindner; Alicia Morresi-Hauf; Christian Vay; Fabian Eder; Bernward Passlick; Christoph A Klein
Journal:  Mod Pathol       Date:  2008-06-20       Impact factor: 7.842

4.  Pulmonary clearance and toxicity of respirable gallium arsenide particulates intratracheally instilled into rats.

Authors:  D R Webb; S E Wilson; D E Carter
Journal:  Am Ind Hyg Assoc J       Date:  1987-07

5.  Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.

Authors:  R E Caffrey-Nolan; K L McCoy
Journal:  Toxicol Appl Pharmacol       Date:  1998-08       Impact factor: 4.219

Review 6.  Implementation of alternative test strategies for the safety assessment of engineered nanomaterials.

Authors:  A E Nel
Journal:  J Intern Med       Date:  2013-07-24       Impact factor: 8.989

7.  Pulmonary response of Fischer 344 rats to acute nose-only inhalation of indium trichloride.

Authors:  M E Blazka; J S Tepper; D Dixon; D W Winsett; R W O'Connor; M I Luster
Journal:  Environ Res       Date:  1994-10       Impact factor: 6.498

8.  Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.

Authors:  E E Sikorski; L A Burns; M L Stern; M I Luster; A E Munson
Journal:  Toxicol Appl Pharmacol       Date:  1991-08       Impact factor: 4.219

9.  Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury.

Authors:  Guillermo M Albaiceta; Ana Gutiérrez-Fernández; Diego Parra; Aurora Astudillo; Emilio García-Prieto; Francisco Taboada; Antonio Fueyo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-25       Impact factor: 5.464

10.  Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers.

Authors:  Rebecca C Fry; Panida Navasumrit; Chandni Valiathan; J Peter Svensson; Bradley J Hogan; Manlin Luo; Sanchita Bhattacharya; Krittinee Kandjanapa; Sumitra Soontararuks; Sumontha Nookabkaew; Chulabhorn Mahidol; Mathuros Ruchirawat; Leona D Samson
Journal:  PLoS Genet       Date:  2007-11       Impact factor: 5.917

View more
  1 in total

Review 1.  Current approaches for safer design of engineered nanomaterials.

Authors:  Ruth Hwang; Vahid Mirshafiee; Yifang Zhu; Tian Xia
Journal:  Ecotoxicol Environ Saf       Date:  2018-09-28       Impact factor: 6.291

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.